Tuned Raises $2.5M Seed Round with Aim to ‘Radically Upend Status Quo’ in Hearing Care
NEW YORK CITY, NEW YORK — Tuned, a hearing health company focused on providing hearing care for all, today announced that it raised $2.5 million in seed funding, led by Idealab NY and Elements Health Ventures. Following successful pilots with companies such as RetailBound and Mishe, the injection of new capital will be used to scale employer adoption and…
Read More
Akouos Receives FDA Clearance of its IND Application for Gene Therapy Hearing Loss Treatment, AK-OTOF
BOSTON, MASSACHUSSETTS — Akouos, Inc. (NASDAQ: AKUS), a precision genetic medicine company dedicated to developing potential gene therapies for individuals living with disabling hearing loss worldwide, announced that it has received clearance from the U.S. Food and Drug Administration (FDA) for its Investigational New Drug (IND) application to initiate a Phase 1/2, first in human,…
Read More
NIH Genomics Researchers Identify Unique Set of Proteins that Restore Hearing in Zebrafish
WASHINGTON, D.C. — National Institutes of Health researchers have discovered a specific network of proteins that is necessary to restore hearing in zebrafish through cell regeneration. The study, led by investigators at the National Human Genome Research Institute (NHGRI), may inform the development of treatments for hearing loss in humans. The findings were published in Cell Genomics.…
Read More
First Patient Enrolled in Clinical Trial of SENS-401 for Residual Hearing Preservation During Cochlear Implantation
MONTPELLIER, FRANCE — Sensorion (FR0012596468 – ALSEN), a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, has announced that the first patient has been enrolled in its proof-of-concept clinical trial of SENS-401 (Arazasetron) in patients scheduled for cochlear implantation.…
Read More
2022 EUHA Congress to Take Place on October 12th
FRANKFURT/MAINZ — The 66th International Congress of Hearing Aid Acousticians (EUHA) and the accompanying Industry Exhibition will provide insights into innovations in the field of hearing on October 12, 2022. More than 25 top-class expert lectures, five tutorials, and four forward-looking Future Friday lectures will be on offer for participants. In addition, they will debut…
Read More
Sony and WS Audiology Announce Partnership on OTC Self-Fitting Hearing Aid Business
TOKYO AND LYNGE, DENMARK — Sony Corporation and WS Audiology Denmark A/S have entered into a partnership agreement and various ancillary agreements with the aim of jointly developing and supplying new products and services in the over-the-counter self-fitting hearing aid market, beginning with the United States. Through the partnership, Sony and WSA will combine their respective technological…
Read More
Sensorion Receives Positive Opinion for Orphan Drug Designation for OTOF-GT from the European Medicine Agency
MONTPELLIER, FRANCE – Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, announces that the European Medicines Agency (EMA) Committee for Orphan Medicinal Products (COMP) has adopted a positive opinion on Sensorion’s application for Orphan…
Read More
Andrew Bellavia Launches AuraFuturity, A Hearing Health and Hearables Consultancy
Andrew Bellavia has today announced the launch of a new consulting business, AuraFuturity, to serve the hearing health and related hearables markets. Focusing on go-to-market, branding, and content, AuraFuturity is positioned to assist innovators to define their value and communicate it effectively to their target customers. “Untreated hearing loss is a global pandemic with more…
Read More
More Than 2500 Hearing Professionals Register for Oticon Own Launch Event
SOMERSET, NEW JERSEY — More than 2,500 hearing care professionals registered for the knowledge-sharing Oticon Own™ launch event, including a live audience at Oticon US headquarters in Somerset, NJ who joined alongside virtual participants from across the US. The launch event introduced Oticon Own™, the world’s first custom hearing aid with an on-board Deep Neural…
Read More
Otolith Labs Raises $20M Series A to Develop Wearable Vertigo Treatment Device
WASHINGTON D.C. — Otolith Labs, a medical technology company developing noninvasive wearable medical devices for the treatment of vestibular disorders, announced the closing of a $20 million Series A financing round by Morningside Ventures. Building on prior investments from businessman Mark Cuban and leading ENT physicians, the proceeds will be used to support the company’s…
Read More